Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Clinical trial NCT04123392 · UNKNOWN

Trial details

NCT number: NCT04123392
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

TP53 Myeloid Tumors Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Start date: 2019-10-01
Primary completion: 2022-09-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.